Cancer Incidence and Mortality for All Sites of Cancer, Richmond County (Staten Island), 2016-2020

Source: New York State Cancer Registry

Site of Cancer Incidence Mortality
Males and Females Males Females Males and Females Males Females
Average Annual Cases Rate per 100,000 Population 95% CI Average Annual Cases Rate per 100,000 Males 95% CI Average Annual Cases Rate per 100,000 Females 95% CI Average Annual Deaths Rate per 100,000 Population 95% CI Average Annual Deaths Rate per 100,000 Males 95% CI Average Annual Deaths Rate per 100,000 Females 95% CI
All Invasive Malignant Tumors 3,041.6 517.4 509.0-525.9 1,474.0 548.2 535.3-561.2 1,567.6 499.0 487.7-510.6 844.2 141.6 137.2-146.0 411.2 161.8 154.7-169.2 433.0 127.5 122.0-133.1
Oral cavity and pharynx
All Oral cavity and pharynx 60.4 10.0 8.9-11.2 42.0 15.1 13.0-17.4 18.4 5.6 4.5-6.9 11.6 1.8 1.4-2.4 8.2 2.9 2.0-3.9 3.4 0.9 0.5-1.5
Lip 0.8 0.2 0.0-0.4 0.6 0.3 0.1-0.8 0.2 0.1 0.0-0.4 0.2 0.0 0.0-0.2 0.0 0.0 0.0-0.3 0.2 0.1 0.0-0.4
Tongue 18.6 3.0 2.4-3.7 13.0 4.5 3.4-5.7 5.6 1.6 1.1-2.4 2.0 0.3 0.1-0.6 1.0 0.4 0.1-0.9 1.0 0.3 0.1-0.7
Salivary gland 8.4 1.5 1.1-2.1 4.6 1.9 1.2-2.9 3.8 1.3 0.8-2.1 1.8 0.3 0.1-0.6 1.4 0.6 0.2-1.2 0.4 0.1 0.0-0.5
Floor of mouth 1.2 0.2 0.1-0.4 1.0 0.3 0.1-0.8 0.2 0.0 0.0-0.4 0.0 0.0 0.0-0.2 0.0 0.0 0.0-0.3 0.0 0.0 0.0-0.3
Gum & other mouth 9.4 1.5 1.1-2.0 5.0 1.9 1.2-2.8 4.4 1.2 0.8-1.9 1.6 0.2 0.1-0.5 1.0 0.3 0.1-0.9 0.6 0.2 0.0-0.5
Nasopharynx 4.2 0.8 0.5-1.2 3.0 1.2 0.6-2.0 1.2 0.4 0.1-0.9 3.2 0.5 0.3-0.9 2.2 0.8 0.4-1.4 1.0 0.3 0.1-0.7
Tonsil 11.2 1.8 1.4-2.4 9.2 3.2 2.3-4.3 2.0 0.6 0.3-1.2 0.6 0.1 0.0-0.3 0.6 0.2 0.0-0.6 0.0 0.0 0.0-0.3
Oropharynx 3.4 0.6 0.3-0.9 2.4 0.8 0.4-1.5 1.0 0.3 0.1-0.8 0.6 0.1 0.0-0.3 0.4 0.1 0.0-0.5 0.2 0.0 0.0-0.4
Hypopharynx 2.2 0.4 0.2-0.7 2.2 0.8 0.4-1.5 0.0 0.0 0.0-0.3 0.4 0.1 0.0-0.2 0.4 0.1 0.0-0.5 0.0 0.0 0.0-0.3
Other buccal cavity and pharynx 1.0 0.1 0.0-0.3 1.0 0.3 0.1-0.7 0.0 0.0 0.0-0.3 1.2 0.2 0.1-0.4 1.2 0.4 0.2-1.0 0.0 0.0 0.0-0.3
Digestive system
All Digestive system 528.0 88.3 84.9-91.9 301.0 111.5 105.7-117.5 227.0 69.2 65.1-73.4 249.0 41.0 38.7-43.4 135.8 51.2 47.3-55.3 113.2 32.9 30.2-35.8
Esophagus 28.4 4.5 3.8-5.3 22.2 7.7 6.3-9.4 6.2 1.9 1.3-2.7 17.6 2.8 2.2-3.5 14.0 4.9 3.8-6.2 3.6 1.1 0.6-1.7
Stomach 47.0 8.1 7.1-9.3 29.0 11.5 9.6-13.6 18.0 5.5 4.4-6.8 22.0 3.8 3.1-4.6 12.2 4.8 3.6-6.2 9.8 3.0 2.2-4.1
Small intestine 15.4 2.6 2.0-3.3 9.2 3.3 2.4-4.5 6.2 2.0 1.4-2.9 2.2 0.3 0.2-0.6 1.2 0.4 0.2-1.0 1.0 0.3 0.1-0.7
Colorectal 240.6 41.0 38.7-43.4 130.2 49.3 45.5-53.4 110.4 34.0 31.2-37.1 80.6 13.4 12.1-14.9 42.6 16.6 14.4-19.1 38.0 10.9 9.4-12.6
Colon excluding rectum 177.4 30.1 28.1-32.2 93.0 35.4 32.2-38.9 84.4 25.7 23.3-28.4 66.4 11.1 9.9-12.4 33.6 13.1 11.2-15.4 32.8 9.5 8.1-11.1
Cecum 27.6 4.6 3.9-5.5 11.0 4.0 3.0-5.3 16.6 4.9 3.9-6.1                  
Appendix 10.8 2.0 1.5-2.6 5.8 2.3 1.5-3.3 5.0 1.6 1.1-2.5                  
Ascending colon 36.8 6.3 5.4-7.3 21.2 8.4 6.9-10.3 15.6 4.6 3.6-5.8                  
Hepatic flexure 6.8 1.1 0.8-1.6 3.8 1.4 0.8-2.2 3.0 1.0 0.5-1.6                  
Transverse colon 15.4 2.6 2.0-3.2 8.8 3.2 2.3-4.4 6.6 2.1 1.4-2.9                  
Splenic flexure 5.8 1.1 0.7-1.6 2.8 1.2 0.6-2.0 3.0 1.0 0.5-1.6                  
Descending colon 11.2 1.9 1.4-2.4 6.0 2.2 1.5-3.2 5.2 1.6 1.1-2.4                  
Sigmoid colon 47.6 8.1 7.1-9.2 25.6 9.6 8.0-11.5 22.0 6.9 5.6-8.4                  
Large intestine, NOS 15.4 2.5 2.0-3.2 8.0 3.0 2.1-4.1 7.4 2.1 1.5-3.0                  
Rectum & rectosigmoid 63.2 10.9 9.7-12.2 37.2 13.9 11.9-16.1 26.0 8.3 6.9-9.9 14.2 2.3 1.8-3.0 9.0 3.5 2.5-4.7 5.2 1.4 0.9-2.1
Rectosigmoid junction 15.6 2.7 2.1-3.4 8.6 3.2 2.3-4.4 7.0 2.2 1.5-3.1                  
Rectum 47.6 8.2 7.2-9.4 28.6 10.7 8.9-12.6 19.0 6.1 4.9-7.5                  
Anus, anal canal & anorectum 11.0 1.8 1.3-2.3 5.0 1.8 1.1-2.7 6.0 1.8 1.2-2.6 2.0 0.3 0.2-0.6 0.8 0.3 0.1-0.9 1.2 0.3 0.1-0.8
Liver and intrahepatic bile duct 65.2 10.3 9.2-11.5 47.2 16.4 14.3-18.7 18.0 5.3 4.2-6.5 39.2 6.3 5.5-7.3 25.4 9.1 7.6-11.0 13.8 4.0 3.1-5.1
Liver 52.6 8.3 7.3-9.4 40.8 14.1 12.2-16.3 11.8 3.4 2.6-4.5 30.0 4.8 4.1-5.7 21.4 7.6 6.2-9.3 8.6 2.5 1.8-3.4
Intrahepatic bile duct 12.6 2.0 1.6-2.6 6.4 2.2 1.5-3.2 6.2 1.8 1.2-2.6 9.2 1.5 1.1-2.1 4.0 1.5 0.9-2.4 5.2 1.5 1.0-2.3
Gallbladder 8.6 1.5 1.1-2.1 2.4 0.9 0.5-1.7 6.2 2.0 1.3-2.9 5.2 0.9 0.6-1.3 2.4 1.0 0.5-1.7 2.8 0.8 0.4-1.4
Other biliary 9.6 1.7 1.2-2.2 4.8 1.9 1.2-2.8 4.8 1.5 1.0-2.3 4.2 0.7 0.4-1.0 1.4 0.5 0.2-1.0 2.8 0.8 0.4-1.4
Pancreas 94.2 15.5 14.1-17.0 46.6 17.0 14.8-19.5 47.6 14.1 12.3-16.1 73.4 12.0 10.8-13.3 35.0 13.2 11.2-15.4 38.4 11.1 9.6-12.9
Retroperitoneum 4.2 0.7 0.4-1.2 2.8 1.1 0.6-1.9 1.4 0.4 0.2-1.0 0.0 0.0 0.0-0.2 0.0 0.0 0.0-0.3 0.0 0.0 0.0-0.3
Peritoneum, omentum & mesentery 1.6 0.3 0.1-0.6 0.4 0.1 0.0-0.5 1.2 0.4 0.1-0.9 1.2 0.2 0.1-0.4 0.0 0.0 0.0-0.3 1.2 0.3 0.1-0.8
Other digestive organs 2.2 0.4 0.2-0.7 1.2 0.4 0.1-1.0 1.0 0.3 0.1-0.8 1.4 0.3 0.1-0.5 0.8 0.4 0.1-1.0 0.6 0.2 0.0-0.6
Respiratory system
All Respiratory system 406.8 67.2 64.3-70.3 198.2 75.2 70.4-80.1 208.6 62.0 58.2-66.0 203.2 34.1 32.0-36.3 102.8 40.6 37.1-44.4 100.4 29.7 27.1-32.5
Nasal cavity, middle ear & sinuses 3.8 0.6 0.4-1.0 1.8 0.7 0.3-1.3 2.0 0.6 0.3-1.1 0.8 0.1 0.0-0.4 0.6 0.3 0.1-0.8 0.2 0.0 0.0-0.4
Larynx 17.6 2.9 2.3-3.6 14.0 5.2 4.0-6.6 3.6 1.1 0.6-1.8 4.2 0.7 0.4-1.0 2.4 0.9 0.4-1.5 1.8 0.5 0.2-1.0
Lung and bronchus 384.8 63.6 60.8-66.6 182.0 69.1 64.6-73.9 202.8 60.3 56.6-64.2 197.0 33.1 31.0-35.3 99.4 39.3 35.8-43.0 97.6 28.8 26.3-31.6
Pleura 0.0 0.0 0.0-0.2 0.0 0.0 0.0-0.3 0.0 0.0 0.0-0.3 0.6 0.1 0.0-0.4 0.4 0.2 0.0-0.7 0.2 0.1 0.0-0.4
Trachea, mediastinum, other respiratory 0.6 0.1 0.0-0.3 0.4 0.2 0.0-0.6 0.2 0.1 0.0-0.4 0.6 0.1 0.0-0.4 0.0 0.0 0.0-0.3 0.6 0.2 0.0-0.7
Soft tissue, bone, and skin
Bones & joints 6.2 1.2 0.8-1.8 3.4 1.4 0.8-2.3 2.8 1.1 0.6-1.9 2.4 0.5 0.3-0.9 1.4 0.7 0.3-1.5 1.0 0.4 0.1-0.9
Soft tissue (including heart) 16.8 3.1 2.5-3.9 8.4 3.2 2.3-4.4 8.4 3.1 2.2-4.3 7.8 1.3 0.9-1.8 2.6 1.0 0.5-1.7 5.2 1.7 1.1-2.5
Skin~ 97.4 16.9 15.4-18.5 52.6 20.4 17.9-23.1 44.8 14.2 12.4-16.3 12.2 2.1 1.6-2.7 6.6 2.8 1.9-3.9 5.6 1.7 1.1-2.5
Melanoma of the skin 84.2 14.4 13.0-15.9 45.6 17.5 15.2-20.0 38.6 12.1 10.4-14.1 8.4 1.5 1.1-2.1 4.2 1.9 1.2-2.9 4.2 1.3 0.8-2.1
Breast
Breast 434.2 75.5 72.2-78.8 3.6 1.3 0.8-2.2 430.6 139.2 133.1-145.4 61.0 10.2 9.0-11.4 0.6 0.2 0.0-0.7 60.4 17.6 15.6-19.8
Breast (in situ)* 142.6 25.7 23.8-27.8 0.4 0.2 0.0-0.7 142.2 48.5 44.8-52.3                  
Female genital system
All Female genital system             203.0 63.8 59.8-68.0             53.2 15.7 13.8-17.7
Cervix uteri             22.2 7.9 6.4-9.6             5.4 1.7 1.1-2.5
Corpus uterus and NOS             116.4 34.9 32.0-37.9             22.0 6.5 5.3-7.8
Ovary             45.6 15.0 13.0-17.1             22.8 6.6 5.4-8.0
Vagina             2.4 0.9 0.4-1.5             0.0 0.0 0.0-0.3
Vulva             8.6 2.6 1.9-3.6             1.8 0.5 0.2-1.1
Other female genital organs             7.8 2.5 1.8-3.5             1.2 0.4 0.1-0.8
Male genital system
All Male genital system       364.4 127.2 121.2-133.3             37.6 16.4 14.1-18.9      
Prostate       347.4 119.5 113.8-125.4             35.8 15.6 13.4-18.2      
Testis       14.2 6.6 5.1-8.3             1.0 0.4 0.1-1.0      
Penis       2.0 0.8 0.4-1.5             0.4 0.1 0.0-0.5      
Other male genital organs       0.8 0.3 0.1-0.8             0.4 0.2 0.0-0.7      
Urinary system
All Urinary system 277.2 46.3 43.8-48.8 196.2 73.7 69.0-78.6 81.0 24.4 22.0-27.0 47.4 8.0 7.0-9.1 32.8 13.4 11.4-15.7 14.6 4.2 3.3-5.4
Urinary bladder (including in situ) 144.4 24.0 22.2-25.8 106.2 40.7 37.2-44.4 38.2 11.2 9.6-12.9 26.8 4.6 3.8-5.4 18.6 7.9 6.4-9.8 8.2 2.4 1.7-3.3
Kidney and renal pelvis 126.0 21.2 19.5-23.0 85.4 31.4 28.4-34.6 40.6 12.6 10.9-14.5 18.8 3.1 2.5-3.9 13.2 5.1 4.0-6.6 5.6 1.6 1.1-2.4
Ureter 4.4 0.7 0.4-1.0 3.0 1.1 0.6-1.8 1.4 0.4 0.2-0.9 0.8 0.1 0.0-0.3 0.6 0.2 0.0-0.7 0.2 0.1 0.0-0.4
Other urinary organs 2.4 0.4 0.2-0.7 1.6 0.6 0.2-1.2 0.8 0.3 0.1-0.7 1.0 0.2 0.1-0.4 0.4 0.1 0.0-0.5 0.6 0.2 0.0-0.6
Eye & orbit
Eye & orbit 6.2 1.1 0.7-1.6 2.0 0.7 0.3-1.4 4.2 1.4 0.9-2.2 0.6 0.1 0.0-0.3 0.0 0.0 0.0-0.3 0.6 0.2 0.0-0.5
Brain and central nervous system
All Brain / other central nervous system (all behaviors) 126.4 22.7 20.9-24.6 48.2 19.1 16.7-21.7 78.2 25.7 23.1-28.5 23.6 4.0 3.3-4.8 12.2 4.5 3.4-5.9 11.4 3.5 2.6-4.5
Malignant brain / other central nervous system 36.4 6.7 5.7-7.8 19.0 7.5 6.1-9.3 17.4 5.9 4.7-7.4 21.6 3.7 3.0-4.5 11.4 4.3 3.2-5.6 10.2 3.1 2.3-4.2
Malignant brain 34.2 6.3 5.4-7.3 18.0 7.2 5.7-8.9 16.2 5.5 4.3-6.9                  
Malignant other central nervous system 2.2 0.4 0.2-0.7 1.0 0.4 0.1-0.9 1.2 0.4 0.1-1.0                  
Benign brain / other central nervous system* 90.0 16.0 14.5-17.6 29.2 11.5 9.7-13.6 60.8 19.8 17.5-22.2 2.0 0.3 0.2-0.7 0.8 0.3 0.1-0.8 1.2 0.3 0.1-0.8
Benign brain 6.2 1.3 0.9-1.8 4.0 1.6 1.0-2.5 2.2 0.9 0.5-1.7                  
Benign other central nervous system 83.8 14.7 13.3-16.2 25.2 9.9 8.2-11.8 58.6 18.8 16.6-21.2                  
Endocrine system
All Endocrine system 170.4 32.9 30.7-35.3 52.8 20.8 18.3-23.6 117.6 44.3 40.7-48.2 3.6 0.6 0.4-1.0 2.0 0.8 0.4-1.5 1.6 0.5 0.2-1.0
Thyroid 164.4 31.8 29.6-34.2 48.6 19.2 16.8-21.9 115.8 43.7 40.1-47.5 3.0 0.5 0.3-0.8 1.6 0.6 0.3-1.3 1.4 0.4 0.1-0.8
Other endocrine (including thymus) 6.0 1.1 0.7-1.5 4.2 1.6 1.0-2.5 1.8 0.6 0.3-1.3 0.6 0.1 0.0-0.4 0.4 0.2 0.0-0.7 0.2 0.1 0.0-0.5
Lymphomas
All Lymphomas 154.4 27.3 25.3-29.3 81.4 31.9 28.8-35.2 73.0 23.4 20.9-26.0 28.4 5.0 4.2-5.9 16.2 6.6 5.2-8.3 12.2 3.6 2.8-4.7
Hodgkin lymphoma 16.0 3.3 2.6-4.1 9.2 3.9 2.8-5.3 6.8 2.7 1.8-3.8 2.6 0.4 0.2-0.8 1.6 0.6 0.2-1.2 1.0 0.4 0.1-0.9
Non-Hodgkin lymphomas 138.4 23.9 22.1-25.9 72.2 27.9 25.0-31.1 66.2 20.7 18.4-23.1 25.8 4.5 3.8-5.4 14.6 6.0 4.7-7.6 11.2 3.3 2.5-4.3
Myeloma
All Myeloma 55.0 9.2 8.1-10.4 29.4 11.2 9.4-13.2 25.6 7.7 6.4-9.2 14.8 2.4 1.9-3.1 8.6 3.2 2.3-4.3 6.2 1.8 1.2-2.6
Leukemias
All Leukemias 98.2 17.4 15.9-19.1 56.8 22.0 19.5-24.8 41.4 13.6 11.8-15.7 37.2 6.5 5.5-7.5 18.8 7.7 6.2-9.5 18.4 5.5 4.4-6.9
Lymphocytic leukemias 47.4 8.4 7.4-9.6 27.6 10.6 8.8-12.6 19.8 6.7 5.4-8.2 8.8 1.5 1.1-2.0 4.8 2.0 1.2-2.9 4.0 1.2 0.7-1.9
Acute lymphocytic leukemia 8.0 1.9 1.3-2.5 3.4 1.6 0.9-2.6 4.6 2.1 1.3-3.1 2.0 0.4 0.2-0.7 0.6 0.3 0.1-0.8 1.4 0.5 0.2-1.0
Chronic lymphocytic leukemia 35.2 5.8 5.0-6.8 20.6 7.7 6.2-9.4 14.6 4.4 3.4-5.6 6.8 1.1 0.8-1.6 4.2 1.7 1.0-2.6 2.6 0.7 0.4-1.2
Other lymphocytic leukemias 4.2 0.7 0.4-1.1 3.6 1.3 0.7-2.1 0.6 0.2 0.0-0.7 0.0 0.0 0.0-0.2 0.0 0.0 0.0-0.3 0.0 0.0 0.0-0.3
Myeloid and monocytic leukemias 45.2 8.1 7.0-9.3 26.2 10.3 8.6-12.3 19.0 6.2 4.9-7.6 19.8 3.5 2.8-4.3 10.2 4.3 3.2-5.6 9.6 3.0 2.2-4.0
Acute myeloid leukemia 29.4 5.3 4.4-6.2 16.4 6.6 5.2-8.2 13.0 4.2 3.2-5.4 17.2 3.0 2.4-3.7 8.8 3.7 2.7-5.0 8.4 2.6 1.8-3.6
Acute monocytic leukemia 1.2 0.2 0.1-0.5 0.8 0.3 0.1-0.8 0.4 0.2 0.0-0.6 0.0 0.0 0.0-0.2 0.0 0.0 0.0-0.3 0.0 0.0 0.0-0.3
Chronic myeloid leukemia 14.0 2.5 2.0-3.2 8.8 3.4 2.4-4.6 5.2 1.7 1.1-2.6 2.0 0.3 0.2-0.6 1.0 0.4 0.1-1.0 1.0 0.3 0.1-0.7
Other myeloid/monocytic leukemias 0.6 0.1 0.0-0.3 0.2 0.1 0.0-0.5 0.4 0.1 0.0-0.5 0.6 0.1 0.0-0.4 0.4 0.2 0.0-0.6 0.2 0.1 0.0-0.5
Other leukemias 5.6 0.9 0.6-1.4 3.0 1.1 0.6-1.8 2.6 0.8 0.4-1.4 8.6 1.5 1.1-2.0 3.8 1.5 0.9-2.4 4.8 1.4 0.9-2.1
Other acute leukemias 1.8 0.3 0.1-0.6 0.8 0.3 0.1-0.8 1.0 0.3 0.1-0.7 3.2 0.5 0.3-0.9 1.0 0.4 0.1-1.0 2.2 0.5 0.3-1.0
Aleukemic, subacute, leukemia NOS 3.8 0.6 0.4-1.0 2.2 0.8 0.4-1.5 1.6 0.5 0.2-1.1 5.4 1.0 0.6-1.4 2.8 1.1 0.6-1.9 2.6 0.8 0.4-1.5
Mesothelioma
Mesothelioma 6.8 1.2 0.8-1.7 4.6 2.0 1.3-3.0 2.2 0.6 0.3-1.2                  
Kaposi sarcoma
Kaposi sarcoma 5.4 1.0 0.6-1.5 4.4 1.8 1.1-2.7 1.0 0.4 0.1-0.9                  
Myelodysplastic syndromes
Myelodysplastic syndromes 21.8 3.8 3.1-4.6 11.2 4.8 3.6-6.3 10.6 3.1 2.3-4.2                  
Chronic myeloproliferative disorders^
Chronic myeloproliferative disorders^ 38.2 6.9 5.9-8.0 17.8 6.9 5.5-8.5 20.4 6.9 5.6-8.4                  
Ill defined and unspecified sites
Ill defined and unspecified sites 54.4 9.5 8.4-10.7 24.8 9.7 8.0-11.6 29.6 9.2 7.7-10.9 52.6 9.0 8.0-10.2 25.8 10.1 8.4-12.0 26.8 8.1 6.7-9.6

Key

Symbol Meaning
~ Incidence of skin cancer excludes basal and squamous cell cancers.
* Breast in situ and Brain/other central nervous system tumors with benign or uncertain behaviors are not included in the total for all invasive malignant tumors.
^ Tumors with a histology of 9963 or 9964 are included under Aleukemic, Subacute, Leukemia NOS, instead of Chronic Myeloproliferative Disorder.

Notes

  • Incidence data are provisional, November 2022.
  • Rates are per 100,000 persons, age-adjusted to the 2000 US standard population, with 95% confidence intervals.
  • Rates based on fewer than 4 cases or deaths per year are unstable and should be used with caution. NOS = Not otherwise specified.